Sequenom call summary: Somewhat awful, not
a gut punch, just a queasy feeling. Sad really.
I'll probably wait a couple months, see if
they can "bundle" some targets together and
raise some cash, to add to the 35M they expect
to have at year end.
"market for target deals not very attractive"
ugh.
I'd probably just piss the money away on more
Lynx, so arguably, doing nothing might be okay too.
Lessee, I'm down 40% each on lynx and sqnm shares.
Not too good there Mike. A smaller loss in TGEN
brings the total to about $24k in just a few months.
That is about 3% of my net worth.
The 4%, or a bit more, that I get in my treasuries
will cover up the mistake and I'll end up about
even for the year, that is good.
I'd rate Lynx a speculative buy right now, sqnm
a sell, tuck may well be right for it to dip a
bit below a buck...and the call is bound to have
a negative effect for a couple of months. So
many targets, good grief! And tgen, I guess
I'd rate a hold, Indian curry spice notwithstanding <g>.
I don't plan on doing any trading however, why
mess with the experiment at all? One out of three
is all I need to salvage the, er, portfolio.
This may go out with a whimper, if my thread
goes quiet and I disappear from SI, here:
zathrasandrenee
at
earthlinknospam
dot net
(don't know if that is enough to disrupt the
span crawlers, but you know what to do)
In about five years I suppose Renee will be
back to work--we may speculate a bit once
again in microcap biotech. Or just spend it
on piano lessons or something <g>. |
